Although the cytostatic effects of PI3K pathway inhibitors have been reported in various types of cancers [9]–[12], targeting the PI3K pathway might induce cytotoxic effects by suppressing anti-apoptotic signals through the dephosphorylation of FOXOs and stabilization of TP53. This evidence concerns the gene TP53 and cancer.